| Tag | Content |
|---|
EnhancerAtlas ID | HS197-22435 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chrX:19881110-19882810 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Mafb | MA0117.2 | chrX:19882773-19882785 | AGTCAGCACTTT | - | 6.32 | | RREB1 | MA0073.1 | chrX:19881820-19881840 | ACACCCAACACCCCCCAACC | + | 6.98 |
|
| | Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
| SE_09810 | chrX:19879669-19890537 | CD14 | | SE_11771 | chrX:19879266-19891591 | CD20 | | SE_32590 | chrX:19879867-19886294 | GM12878 | | SE_58605 | chrX:19810059-19915925 | Ly1 | | SE_60015 | chrX:19844904-19906955 | Ly4 | | SE_60833 | chrX:19844705-19907071 | DHL6 | | SE_66807 | chrX:19882039-19884187 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH0XI019862 | chrX | 19880532 | 19886365 |
|
Enhancer Sequence | CAGCAGTCTG CCCCCTTCAG AGAAGAGGCC CAGGACTGTC AGGGGCCATT GTCAACCACT 60
AAAGGAGGAC CCTGTCCCCT CCCTGGGGGT TAGCTGAATC CCGGCACTGG AATACAGTGG 120
CATCTGCCTT GAATGTCTCT TTCCCAAAAG GGGCCCGGCC AGAGGGCTCA AGCTTTGCTG 180
AGCTTACAAA ACAGACTGCA GTGTGCTCTC TTTTTTTTTT AAAGAGACAG GGTCTTGCTC 240
TGTTGCCCAG GCTGGAGTAC AGTGACAGGA TCATAGCTCA CTACAGCCTT GAACTCCTGA 300
GCTCAAGTAA TCCTTCCACC TCAGCCTCCC AAGTAACAGG GACTATAGGT ATGTGCCACC 360
ACGCCCAGCT AAAGCAGGGC TCTCTTCATG CCTGCTTACT AACAAGTGTC TGAATGAGTG 420
GCCAAAACGT GTCTGAGACT TGCTTTCACT GTAACATACC TCCCAGTCAT GGGACCGTGG 480
GAAAGGATGC ACAAAGCTCC CACGTACTAT TTCTCAAAAG AACTTGTCAG TTCTTCAAAG 540
TCCAAACCAG TTTAAGTTCA CAACAGATTA TTTGTTAGAA TTCTTGAGAA CACATTTAAG 600
GCTCTGTGAG CCTGTACCAG ACCGGTTTAC ATTCTCCAGA GCAGAGCCCT CCTGGGACGG 660
GGTCCCCAGC TGGGCTGCTG CTCTCTCCAG AGAGAGTTGT TTGGACAGTG ACACCCAACA 720
CCCCCCAACC TCCCTCGGGA CACCAAGTGG CCACAATGAA CCCCTGAGGC TTTTAGTGGC 780
AAGAGTGCAC TGGATGTCCA AAAAGTAAGC AAATAAATTT GTTTAGCCCA GCGTCTAAGT 840
TGACTCAACA GTAGAATCAA TCACAAAGCC TACAAACAAA AAAGCCCATG CTTTTATTTT 900
CTTTGGGGCC AGATGTAATC AACCCCATCT TCTATTTTCT CTCTCCCAAG GGGCAGACTC 960
GTCTATCATT TCCTGTCCTC ATCCCCCTGC TTCCTCATTC CTCGCTCGCT GGCCAGCCCA 1020
GCTGCTACCA GTCATCCTAA CTCCCTGCTC CCCTTCACAG CCATCCATCC CCAGGCTCTA 1080
GCAGCCCCTG GTAAGAGTCT CAGCTGGGAT CATCAAAACT CCAGGACCAC CCTACAGAGA 1140
AACAAGGTAT CTGACAAACT TCACAGTCTA GTGGTCTAAG AGAAACCCTC TCAACTTCCT 1200
GAAACTCTGC AAATATAGAA GCCATCTTCC ACGTAGGCTG CCACCAAAAT GATTGCCCCT 1260
TTGGCCCTAC CCGACATGGA GATTTAGGAA AACAAAGTCC CTGGTGTGGA TTGGCAGAAC 1320
AACACCCCCC CACCCCCTGC AAAGATTTCC ACATCCCAAT CCCAAGCAAA AGGGAATGAA 1380
AGTTGCAGAT GGAATTAAGG TTGCTCATCA GCTGGCCTTA CAAAAGGAAG AGTCGCCTGG 1440
ATTATCCAGG TGGACCCAAT GTACCCACAA GGGTTCTTAA AAAGAGAGCG GGGGCACAGG 1500
AGAGAAGATC AAGTGACACA ACCTGAAAAG GACCTGGGTC ACTGTTGGTG GCTTTGAAGA 1560
TGGAGGAAGG GGTCATGAGC CAAGGAATAC GGGCTGCCTC TAGAAGATGG GAAATGGAAG 1620
GGAACGGGAT TTTCCTTAGA GTTTCCAAAA AGGAATGCAG CCCAGTCAGC ACTTTGATTT 1680
TAGCCCAGTG AGACCCACAT 1700
|
